entertainment -WSS

entertainment

author：fashion 2025-09-03 09:27:28 - browse：51

The building exterior of AstraZeneca, a pharmaceutical and biopharmaceutical company, under cloudless blue sky — coverage from STAT — Adobe

WILMINGTON, Del. — Wednesday was the first time that a federal judge asked questions in-person of drug industry lawyers who are trying to stop Medicare from negotiating drug prices. It didn’t go well for them.

AstraZeneca’s lawyers argued that Medicare’s new powers amount to a taking of their property rights without due process. But Colm Connolly, chief judge of the U.S. District Court of Delaware, said he doesn’t understand how the law deprives AstraZeneca of its property. He asked Catherine Stetson, who represents AstraZeneca, multiple times to explain what property the company would lose due to Medicare price negotiation. Stetson said it’s both the patent and the drug that’s subject to the patent.

“You’re free to do what you want,” Connolly said, adding that drug companies don’t have to sell to Medicare. “You may not make as much money.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

leisure time

WSS

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Novo Nordisk to expand supply of Wegovy for U.S. patients

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Time to name cancers by genetics, not organ of origin, expert says

The problems with dementia villages

STAT Summit: Meghan O’Rourke on making chronic illness visible

entertainment

entertainment

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Smaller biotechs seek to piggyback on weight loss drug boom

Apple is now the first public company to be valued at $3 trillion

Vertigo drug brings hope for rare neuron disorder, Niemann

Guidelines to prevent youth baseball injuries need more muscle

Novo Nordisk to expand supply of Wegovy for U.S. patients

Jerome Adams on the need for new antivirals for Covid

Commercial surrogacy can be ethical, despite pope’s claims

DIEP, the 'gold standard' of breast reconstruction, is under threat

Vertex non

hotspot

STAT Readout Newsletter: Biotech news today

A $475,000 price tag for a new cancer drug: crazy or meh?

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

Cassava Sciences’ Alzheimer’s clinical trials should be halted

The real point of Kenneth Smith’s execution by nitrogen gas

Is there really a nursing shortage in the U.S.?

knowledge

hotspot

leisure time

focus